Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP block versus local infiltration for analgesia after laparoscopic inguinal hernia repair
2024-515759-39-00Phase 4Authorised
- Sponsor
- UZ Brussel
- Start
- Nov 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ropivacaine in inguinal hernia (2 arms), sponsored by UZ Brussel. Primary endpoint: Postoperative pain (Numeric Rating Scale). Planned start Nov 2024; status: authorised.
02
Drugs
ropivacaine
03
Conditions
inguinal hernia
Beyond the preview
Go deeper on 2024-515759-39-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515759-39-00.